Jonathan Javitt

Johns Hopkins School of Medicine

Adjunct Professor

Baltimore, MD

Potomac Institute for Policy Studies

901 N. Stuart Street

Suite 200

Arlington, VA 22203

United States

NeuroRx

NeuroRx, Inc.

913 N. Market Street

Wilmington, DE 19801

United States

http://www.neurorxpharma.com

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 6,119

SSRN RANKINGS

Top 6,119

in Total Papers Downloads

8,252

SSRN CITATIONS

2

CROSSREF CITATIONS

1

Ideas:
“  Development of vasoactive intestinal peptide for the treatment of COVID-19, ARDS, Sarcoidosis, and Asthma/Allergy  ”

Scholarly Papers (3)

VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

Number of pages: 12 Posted: 04 Aug 2020 Last Revised: 26 Oct 2020
Houston Methodist Research Institute, Johns Hopkins School of Medicine, Boston Biostatistical Research Foundation, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital and Houston Methodist Hospital
Downloads 5,971 (1,361)

Abstract:

Loading...

VIP, vasoactive intestinal peptide, aviptadil, SARS-CoV-2, corona virus, COVID-19, respiratory failure, IL6, ARDS

Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide

Number of pages: 10 Posted: 18 Sep 2020
Houston Methodist Research Institute, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital and Johns Hopkins School of Medicine
Downloads 1,034 (24,330)

Abstract:

Loading...

VIP, Vasoactive Intestinal Peptide, Aviptadil, COVID-19, SARS-CoV-2, Antiviral

2.

VIP: A COVID-19 Therapeutic that Blocks Coronavirus Replication

Number of pages: 9 Posted: 12 Aug 2020 Last Revised: 29 Oct 2020
Jonathan Javitt and Jihad G. Youssef
Johns Hopkins School of Medicine and Houston Methodist Research Institute
Downloads 1,060 (23,862)

Abstract:

Loading...

VIP, Aviptadil, COVID-19, coronavirus, SARS-CoV-2, viral replication, cytokine, surfactant, calu-3

3.

Treatment of Sepsis-related Acute Respiratory Distress Syndrome with Vasoactive Intestinal Peptide

Number of pages: 11 Posted: 07 Aug 2020 Last Revised: 19 Aug 2020
Houston Methodist Research Institute, State University of New York (SUNY), Stony Brook (desceased), University of Houston, New York University (NYU) - Langone Medical Center and Johns Hopkins School of Medicine
Downloads 187 (188,425)
Citation 3

Abstract:

Loading...

ARDS, VIP, Aviptadil, RLF-100, Acute Respiratory Distress Syndrome, Sepsis